Pharmacokinetics of chlordesmethyldiazepam after single-dose oral administration in humans
The pharmacokinetics of chlordemethyldiazepam — a pharmacologically very active new 1,4-benzodiazepine derivative — in healthy subjects after administration of a single oral dose of 2 mg, was studied. Peak concentrations were reached in 1.2 ± 0.2 hours. Plasma levels declined with a biphasic pattern, and the elimination phase had a half-life of 82.9 ± 14.1 hours. The concentrations of the main metabolite of chlordemethyldiazepam, lorazepam, were about 7% of those of the parent compound. In urine only conjugated lorazepam could be found its 96 hour excretion reaching about 15% of the administered dose of parent drug.
Key-wordsChlordemethyldiazepam pharmacokinetics metabolism
Unable to display preview. Download preview PDF.
- 3.Castellani A., Colafeiice M., Lorini M. and Perbellini D. (1979): A single blind, crossover comparison of the anxiolitic activity of chlordemethyldiazepam: analysis of single item changes. Clin. Ther.,2, 343–351.Google Scholar
- 4.Agricola A., Mazzarino M., Agricola R., Urani R. and Fresia P. (1981): A double-blind, crossover clinical trial of chlordemethyldiazepam versus lorazepam in neurotic inpatients: activity on anxiety-depression symptoms. Clin. Ther.,4, 339–408.Google Scholar
- 8.De Silva J.A.F., Bekersky I. and Puglisi C.V. (1973): The determination of 7-chloro-1,3-dihydro-5-(2,chlorphenyl)-2H-1,4-benzodiazepin-2-one (RO-5-3027) and its metabolite (lorazepam) in blood and urine by electron-capture gas-liquid chromatography. J. Chrom. Sc.,11, 547–554.Google Scholar
- 11.Bareggi S.R., Nielsen N.P., Leva S., Pirola R., Zecca L. and Lorini M. (1986): Age-related multiple-dose kinetics and anxiolytic effects of Delorazepam (Chlordesmethyldiazepam). Int. J. Clin. Pharm. Res.,6, 309–314.Google Scholar